Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

High bone density due to a mutation in LDL-receptor-related protein 5.

Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP.

N Engl J Med. 2002 May 16;346(20):1513-21.

PMID:
12015390
[PubMed - indexed for MEDLINE]
Free Article
2.

Regulation of bone formation and vision by LRP5.

Patel MS, Karsenty G.

N Engl J Med. 2002 May 16;346(20):1572-4. No abstract available.

PMID:
12015398
[PubMed - indexed for MEDLINE]
3.

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML; Osteoporosis-Pseudoglioma Syndrome Collaborative Group.

Cell. 2001 Nov 16;107(4):513-23.

PMID:
11719191
[PubMed - indexed for MEDLINE]
Free Article
4.

Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.

Rickels MR, Zhang X, Mumm S, Whyte MP.

J Bone Miner Res. 2005 May;20(5):878-85. Epub 2004 Dec 20.

PMID:
15824861
[PubMed - indexed for MEDLINE]
5.

LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.

Levasseur R, Lacombe D, de Vernejoul MC.

Joint Bone Spine. 2005 May;72(3):207-14. Review.

PMID:
15850991
[PubMed - indexed for MEDLINE]
6.

Wnt signalling: antagonistic Dickkopfs.

Zorn AM.

Curr Biol. 2001 Aug 7;11(15):R592-5.

PMID:
11516963
[PubMed - indexed for MEDLINE]
Free Article
7.

High-bone-mass disease and LRP5.

Whyte MP, Reinus WH, Mumm S.

N Engl J Med. 2004 May 13;350(20):2096-9; author reply 2096-9. No abstract available. Erratum in: N Engl J Med. 2004 Sep 2;351(10):1038.

PMID:
15141052
[PubMed - indexed for MEDLINE]
Free Article
8.

[Cytokines in bone diseases. Wnt signaling and osteoporosis-pseudoglioma syndrome].

Ozono K.

Clin Calcium. 2010 Oct;20(10):1520-5. doi: CliCa101015201525. Review. Japanese.

PMID:
20890034
[PubMed - indexed for MEDLINE]
9.

Cloning and expression of Xenopus Lrp5 and Lrp6 genes.

Houston DW, Wylie C.

Mech Dev. 2002 Sep;117(1-2):337-42.

PMID:
12204281
[PubMed - indexed for MEDLINE]
Free Article
10.

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D.

J Biol Chem. 2005 May 20;280(20):19883-7. Epub 2005 Mar 18.

PMID:
15778503
[PubMed - indexed for MEDLINE]
Free Article
11.

The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.

Johnson ML.

J Musculoskelet Neuronal Interact. 2004 Jun;4(2):135-8. Review.

PMID:
15615112
[PubMed - indexed for MEDLINE]
Free Article
12.

LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.

He X, Semenov M, Tamai K, Zeng X.

Development. 2004 Apr;131(8):1663-77. Review.

PMID:
15084453
[PubMed - indexed for MEDLINE]
Free Article
13.

High bone density due to a mutation in LDL-receptor-related protein 5.

Little RD, Recker RR, Johnson ML.

N Engl J Med. 2002 Sep 19;347(12):943-4; author reply 943-4. No abstract available.

PMID:
12239268
[PubMed - indexed for MEDLINE]
Free Article
14.

The role of the Wnt signaling pathway in osteoblast commitment and differentiation.

Yavropoulou MP, Yovos JG.

Hormones (Athens). 2007 Oct-Dec;6(4):279-94. Review.

PMID:
18055419
[PubMed - indexed for MEDLINE]
Free Article
15.

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Bénichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W.

Am J Hum Genet. 2003 Mar;72(3):763-71. Epub 2003 Feb 10.

PMID:
12579474
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.

Ai M, Heeger S, Bartels CF, Schelling DK; Osteoporosis-Pseudoglioma Collaborative Group.

Am J Hum Genet. 2005 Nov;77(5):741-53. Epub 2005 Sep 27.

PMID:
16252235
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Wnt signaling: an embarrassment of receptors.

Bejsovec A.

Curr Biol. 2000 Dec 14-28;10(24):R919-22. Review.

PMID:
11137030
[PubMed - indexed for MEDLINE]
Free Article
18.

The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd.

Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D.

Mol Cell Biol. 2004 Jun;24(11):4677-84.

PMID:
15143163
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.

Lev D, Binson I, Foldes AJ, Watemberg N, Lerman-Sagie T.

Isr Med Assoc J. 2003 Jun;5(6):419-21.

PMID:
12841014
[PubMed - indexed for MEDLINE]
Free Article
20.

Wnt signaling and osteoblastogenesis.

Bodine PV, Komm BS.

Rev Endocr Metab Disord. 2006 Jun;7(1-2):33-9. Review.

PMID:
16960757
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk